Sign in
4

Changes in Ownership

abrdn Life Sciences Investors Filed Acc 0001510281-24-000319

10% owner bought 59,440 shares at an average $13.61 ($809,222)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Saba Capital Management, L.P. 10% owner 2024-06-04 Purchase +33,357 $13.50 $450,320 3,354,025 I
Saba Capital Management, L.P. 10% owner 2024-06-05 Purchase +26,083 $13.76 $358,902 3,380,108 I
Open-market purchases · 59,440 sh · avg $13.61 · $809,222
Loading xslF345X05/primary_doc.xml…